Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
CRA International
CRAI
$1.06B
| $6.4M | ﹤0.01% |
74,809
-2,001
| -3% | -$163K |
|
2377
Relmada Therapeutics
RLMD
$512M
| $6.37M | ﹤0.01% |
199,124
+9,580
| +5% | +$333K |
|
|
GTM
2378
ZoomInfo Technologies
GTM
$1.18B
| $6.37M | ﹤0.01% |
122,069
+64,740
| +113% | +$3.04M |
|
2379
SiTime
SITM
$21.4B
| $6.34M | ﹤0.01% |
50,049
+4,784
| +11% | +$489K |
|
2380
German American Bancorp
GABC
$1.93B
| $6.33M | ﹤0.01% |
170,087
-3,857
| -2% | -$162K |
|
2381
Par Pacific Holdings
PARR
$4.02B
| $6.32M | ﹤0.01% |
375,433
-57,793
| -13% | -$869K |
|
2382
BNY Mellon Emerging Markets Equity ETF
BKEM
$92M
| $6.29M | ﹤0.01% |
245,091
-9,597
| -4% | -$243K |
|
2383
Pan American Silver
PAAS
$20B
| $6.28M | ﹤0.01% |
219,790
-13,061
| -6% | -$421K |
|
2384
Century Aluminum
CENX
$4.62B
| $6.27M | ﹤0.01% |
486,373
-21,521
| -4% | -$310K |
|
2385
WisdomTree US Total Dividend Fund
DTD
$1.7B
| $6.23M | ﹤0.01% |
105,200
-7,650
| -7% | -$450K |
|
2386
Seres Therapeutics
MCRB
$45.6M
| $6.21M | ﹤0.01% |
13,029
+2,657
| +26% | +$1.12M |
|
2387
Elbit Systems
ESLT
$36.7B
| $6.21M | ﹤0.01% |
47,835
-3,108
| -6% | -$422K |
|
|
LL
2388
DELISTED
LL Flooring Holdings, Inc.
LL
| $6.2M | ﹤0.01% |
293,785
-20,674
| -7% | -$487K |
|
2389
Brookdale Senior Living
BKD
$3.02B
| $6.19M | ﹤0.01% |
783,635
-125,156
| -14% | -$900K |
|
2390
Anika Therapeutics
ANIK
$288M
| $6.18M | ﹤0.01% |
142,752
-15,057
| -10% | -$641K |
|
2391
Relay Therapeutics
RLAY
$4.35B
| $6.12M | ﹤0.01% |
167,373
+28,508
| +21% | +$939K |
|
|
TBIO
2392
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $6.12M | ﹤0.01% |
222,270
-21,444
| -9% | -$421K |
|
2393
NVE Corp
NVEC
$587M
| $6.11M | ﹤0.01% |
82,505
-640
| -0.8% | -$45.6K |
|
2394
Paysafe
PSFE
$340M
| $6.1M | ﹤0.01% |
+41,981
| New | +$6.3M |
|
|
EMTL
2395
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
| $6.05M | ﹤0.01% |
118,513
+18,278
| +18% | +$924K |
|
2396
iShares S&P 100 ETF
OEF
$20.5B
| $6.04M | ﹤0.01% |
30,777
-134
| -0.4% | -$25.5K |
|
2397
Anavex Life Sciences
AVXL
$298M
| $5.97M | ﹤0.01% |
261,167
+56,344
| +28% | +$835K |
|
2398
Castle Biosciences
CSTL
$905M
| $5.97M | ﹤0.01% |
81,355
+3,342
| +4% | +$221K |
|
2399
Liquidity Services
LQDT
$1.36B
| $5.96M | ﹤0.01% |
234,048
-23,795
| -9% | -$524K |
|
|
LBAI
2400
DELISTED
Lakeland Bancorp Inc
LBAI
| $5.94M | ﹤0.01% |
339,865
-21,917
| -6% | -$398K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.